Hexarelin
Most potent GHRP with cardioprotective and GH-releasing properties
Clinical Research Score: 4/5 — Studied in human trials for growth-hormone release and cardiovascular effects, though it never reached approval.
Categories: Hormonal Support, Recovery & Repair
What is Hexarelin?
Hexarelin is the most powerful growth hormone releasing peptide available — period. It produces the largest GH pulse of any GHRP, making it the choice for people who want maximum growth hormone output.
People report impressive strength gains, rapid recovery, and noticeable body composition changes. The GH pulse is substantial enough to deliver visible results in relatively short timeframes. The cardioprotective benefits are a unique bonus — Hexarelin protects heart tissue in ways that are independent of its GH-releasing effects.
The trade-off is desensitization. The pituitary can become less responsive to Hexarelin with continuous use, so most protocols involve cycling — periods of use followed by breaks. This isn't unusual in the peptide world, but it requires more planning than "set and forget" peptides like Ipamorelin. For short, intensive GH-boosting phases, or for people who respond well to cycling protocols, Hexarelin delivers unmatched potency.
How Hexarelin works
Hexarelin activates the GHSR with the highest potency of any GHRP, triggering maximum growth hormone release from the pituitary. What makes it unique is its additional interaction with the CD36 receptor, which provides direct cardioprotective effects — protecting heart tissue from ischemia (lack of blood flow) and reducing cardiac fibrosis (scarring). These heart-protective benefits occur independently of the GH release, making Hexarelin a dual-purpose compound.
Scientific overview
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that is considered the most potent GHRP for stimulating growth hormone release. Beyond its GH-releasing effects, Hexarelin has demonstrated significant cardioprotective properties independent of GH release, including protection against ischemia-reperfusion injury and improvement of cardiac function.
Dosing
- Starting dose: 100 mcg per dose
- Common dosage range: 100-200 mcg per dose
- Administration: Subcutaneous
- Half-life: ~70 minutes
- Frequency: 2-3x daily (cycle to avoid desensitization)